As HRPPs, we shouldn’t say that a study meets the criteria for approval if it excludes vulnerable populations just because including them would mean a bit of extra paperwork for researchers and us. If we can ensure that the research we approve doesn’t exclude people simply because it’s easier, we can help research become more diverse. Read more
PRIM&R stands in solidarity with the Jewish community by participating in the Anti-Defamation League (ADL)’s Hanukkah Shine A Light program, a national campaign created in response to increased antisemitism in 2021 in the United States. Read more
PRIM&R’s Annual Conference is some of the few days each year when everybody agrees that federal regulations are somehow appropriate for dinner conversation, I tried to steer the conversation that way at Thanksgiving, and it did not go well. Since I primarily work with SBE researchers, most of the sessions of the most interest to me are on that path. Read more
I was working at my first “real” full-time job after college as a research assistant on clinical trials for Alzheimer’s disease when the HIPAA Privacy Rule first rolled onto the scene (let’s not do the math on this, it makes me feel old). I remember many in the research community having one of two immediate reactions to the new requirements: either “Oh my gosh, this is going to bring research to a screeching halt” or “This is completely unnecessary; we already get informed consent from participants so why do we need HIPAA?” While this is all ancient history now, and we obviously know that neither was research in the U.S. hobbled nor was HIPAA abandoned, it [...] Read more
How many of you can relate to this? I’m sure I’m not alone! To paraphrase a common idiom, “We may not have it all together, but together we have . . . most of it.” So, let’s all meet up at the all virtual 2022 PRIM&R Annual Conference(PRIMR22) December 12 -15 with workshops December 6 & 8! There is a packed agenda with crossover content for the entire research community. Read more
